Delek US
DK
$75.67
+0.36%
Delek US Holdings, Inc. is an integrated downstream energy company operating three primary segments — petroleum refining, logistics, and retail convenience stores — with a refining footprint concentrated in the U.S. Gulf Coast and Southeast that produces gasoline, diesel, and jet fuel for transportation and industrial markets. Unlike the integrated majors, Delek is a pure-play independent refiner whose earnings are highly levered to crack spreads, making it a high-beta play on refining margins rather than a diversified energy platform. The current investor narrative has been dominated by an extraordinary margin windfall: geopolitical supply disruptions (including the Iran conflict and a competitor refinery fire) have driven jet fuel and distillate cracks to multi-year highs, propelling the stock up roughly 130% over the past year and 149% year-to-date. Management's own valuation commentary suggesting the shares could double, combined with a Q1 earnings beat and a raised dividend at the Delek Logistics level, has reinforced the bull case, though the recent dilutive equity offering at Delek Logistics and stretched balance-sheet leverage have introduced a countervailing cautionary thread.…
DK
Delek US
$75.67
Related headlines
Investment Opinion: Should I buy DK Today?
The synthesized recommendation is Hold. The core thesis is that Delek's current earnings windfall is likely unsustainable, and while the forward valuation appears attractive, the extreme balance sheet leverage and cyclical margin dependency introduce substantial risk. The analyst consensus rating of 'buy' with an average target of $74.58 suggests the stock is fairly valued at current levels, offering no clear margin of safety.
Supporting evidence includes the forward PE of 8.99x, which is below the 12-14x typical for integrated majors, and the PEG ratio of 0.816, indicating undervaluation relative to growth. Revenue growth of 47.83% year-over-year in Q2 2026 and a swing to positive net income of $169.5 million demonstrate operational leverage. However, the debt-to-equity ratio of 11.70 and current ratio of 0.818 highlight financial fragility. The dividend yield of 3.44% is attractive, but the payout ratio is negative, raising sustainability concerns.
Key risks that could invalidate the thesis include a sharp decline in refining margins, which would pressure earnings and cash flow, and the company's high leverage, which limits financial flexibility. The rating would upgrade to Buy if margins show structural support and leverage decreases, or downgrade to Sell if margins normalize and liquidity tightens. Relative to its history and peers, the stock appears overvalued on a price-to-book basis but undervalued on forward earnings multiples, resulting in a balanced valuation verdict.
Sign up to view all
DK 12-Month Price Forecast
The outlook for Delek is balanced but with significant risks. The company is currently benefiting from a margin windfall that has driven explosive earnings growth, but this is likely unsustainable. The valuation appears attractive on forward earnings, but the extreme leverage and cyclical nature of refining pose substantial downside risk. The analyst consensus is neutral-to-bullish, but the stock is trading at fair value. I would upgrade to bullish if margins show structural support and leverage decreases, and downgrade to bearish if margins compress sharply or liquidity concerns emerge.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Delek US's 12-month outlook, with a consensus price target around $74.58 and implied upside of -1.4% versus the current price.
Average Target
$74.58
0 analysts
Implied Upside
-1.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$52 - $90
Analyst target range
Twelve analysts cover Delek, with a consensus recommendation of "buy" (mean rating of 2.0 on a 1-5 scale where lower is more bullish) and an average price target of $74.58, which implies essentially zero upside from the current price of $74.19 — the stock has already caught up to consensus. The Buy/Hold/Sell distribution skews bullish, with recent ratings from Raymond James (Outperform), TD Cowen (Buy), Wells Fargo (Overweight), Goldman Sachs (Buy), and Mizuho (Outperform) offset by Morgan Stanley (Equal Weight) and JP Morgan (Neutral), suggesting the sell-side is constructive but not uniformly so. The consensus EPS estimate of $7.70 for the forward period, against a low estimate of $5.66 and a high of $9.33, reveals a wide 65% spread between the most bearish and most bullish earnings forecasts — a clear signal of high uncertainty around refining margin assumptions. The target price range spans from $52.00 to $90.00, a 73% spread that is unusually wide and reflects genuine disagreement about the durability of current crack spreads. The high target of $90.00 implies roughly 21% upside and likely assumes sustained geopolitical supply disruptions, continued jet fuel margin strength, and multiple expansion as the market re-rates the stock on forward earnings; the low target of $52.00 implies roughly 30% downside and likely prices in margin normalization, balance-sheet stress from the 11.70 debt-to-equity ratio, and a return to mid-cycle refining economics. Notably, the institutional ratings show no upgrades or downgrades in the recent data — every action is a reiteration of the prior rating — which suggests analysts are in a holding pattern, waiting for evidence on whether the margin windfall persists. The wide target spread combined with the stock trading essentially at consensus fair value means the risk/reward is balanced, and the direction of the next move likely hinges on macro refining margin data rather than company-specific catalysts.
Bulls vs Bears: DK Investment Factors
The bull case currently has stronger evidence, driven by the dramatic margin recovery, explosive revenue growth, and attractive forward valuation metrics. However, the bear case is compelling due to the extreme leverage, cyclical margin dependency, and technical overextension. The single most important tension is the durability of the refining margin windfall: if geopolitical disruptions persist, the stock could re-rate higher; if margins normalize, the downside could be severe given the balance sheet fragility. The risk/reward is balanced, with the stock trading at consensus fair value and the next move likely hinging on macro refining margin data.
Bullish
- Explosive revenue growth: Q2 2026 revenue surged 47.83% year-over-year to $4.087 billion, the highest in the dataset, driven by elevated refining throughput and pricing. This top-line acceleration marks a sharp reversal from the weakness in 2024 and early 2025.
- Dramatic margin recovery: Gross margin swung from negative 2.66% in Q1 2026 to positive 8.93% in Q2 2026, while net income turned from a $201.3 million loss to a $169.5 million profit. EBITDA reached $621.5 million, a 15.21% margin, demonstrating powerful operating leverage.
- Attractive forward valuation: The forward PE of 8.99x is below the typical 12-14x for integrated majors, and the PEG ratio of 0.816 is under 1.0, signaling undervaluation relative to expected growth. EV/EBITDA of 5.79x also sits below the 6-8x refiner range.
- Strong free cash flow generation: TTM free cash flow is $684.9 million, with positive quarterly FCF in three of the last four quarters, including $386.4 million in Q4 2025. This cash generation supports debt servicing and potential shareholder returns.
Bearish
- Extreme balance sheet leverage: Debt-to-equity stands at 11.70 and total debt-to-capitalization at 88.51%, leaving little financial flexibility. The current ratio of 0.818 indicates current liabilities exceed current assets, signaling tight near-term liquidity.
- Cyclical margin dependency: The current windfall is geopolitically driven, not structural; refining margins are highly cyclical. A normalization of crack spreads could quickly reverse the profitability, as evidenced by the Q1 2026 net loss of $201.3 million.
- Stretched technicals and overextension: The stock has surged 129.76% over the past year and 149.13% YTD, sitting at 86.5% of its 52-week range. The recent 18% drawdown from the September 17 high of $81.55 to $66.91 in five sessions highlights vulnerability to sharp reversals.
- Valuation premium on book value: The price-to-book ratio of 6.28 is elevated for a refiner, which typically trades between 1.5x and 3x. This suggests the market is pricing in a structurally higher earnings plateau that may not be justified by cyclical margins.
DK Technical Analysis
Delek is in a powerful, sustained uptrend that has carried the shares 129.76% higher over the past year and 149.13% year-to-date, with the current price of $74.19 sitting at roughly 86.5% of the 52-week range (low of $25.85, high of $82.27). That positioning near the upper end of the annual range signals strong momentum but also meaningful overextension risk, particularly given the stock has nearly tripled off its lows. The 52-week high of $82.27 was set intraday on September 17, and the failure to reclaim it since suggests the market is digesting gains rather than pressing the advance. Short-term momentum remains constructive but is decelerating: the 1-month change of +3.83% and 3-month change of +41.02% are both positive, yet the 1-month figure is a fraction of the 3-month pace, indicating the rate of ascent is cooling. This deceleration is corroborated by the pullback from the September 17 high of $81.55 to the September 24 low of $66.91 — a roughly 18% drawdown in just five sessions — before stabilizing back to $74.19. Relative strength versus the S&P 500 remains emphatic across every window (+3.24% over 1 month, +37.68% over 3 months, +114.75% over 1 year), confirming this is genuine outperformance rather than beta-driven drift. Key technical support sits at the 52-week low of $25.85, though the more actionable near-term support is the $66.91 September swing low, with resistance at the $82.27 52-week high. A decisive breakout above $82.27 would signal a fresh leg higher and likely invite momentum-chasing flows, while a breakdown below $66.91 would threaten the intermediate uptrend and open the door to a deeper mean-reversion toward the $60 area. The stock's beta of 0.569 is notably low — roughly 43% less volatile than the S&P 500 on a historical basis — which is unusual for a refiner and implies that position sizing can be more aggressive than a typical high-beta energy name would warrant, though the recent 18% five-day drawdown shows realized volatility can spike sharply around margin-driven news.
Beta
0.60
0.60x market volatility
Max Drawdown
-36.0%
Largest decline past year
52-Week Range
$26-$82
Price range past year
Annual Return
+136.3%
Cumulative gain past year
| Period | DK Return | S&P 500 |
|---|---|---|
| 1m | +5.3% | +1.2% |
| 3m | +35.0% | +4.5% |
| 6m | +84.1% | +14.6% |
| 1y | +136.3% | +16.0% |
| ytd | +154.1% | +14.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
DK Fundamental Analysis
Delek's revenue trajectory has inflected sharply upward, with Q2 2026 revenue of $4.087 billion representing 47.83% year-over-year growth versus the prior-year quarter, a dramatic reversal from the weakness that characterized 2024 and early 2025. The sequential progression tells the story: revenue climbed from $2.653 billion in Q1 2026 to $4.087 billion in Q2 2026, and the refining segment is overwhelmingly the driver at $4.056 billion versus just $384.7 million from logistics. The prior-year comparison base was depressed — Q2 2025 revenue was $2.765 billion with a net loss of $106.4 million — so the growth rate partly reflects easy comparables, but the absolute revenue level is the highest in the dataset and reflects genuinely elevated throughput and pricing. The key question for the investment case is durability: refining margins are cyclical, and the current windfall is geopolitically driven rather than structural, meaning revenue could normalize quickly if crack spreads compress. Profitability has swung decisively from deep losses to robust earnings, with Q2 2026 net income of $169.5 million and a 4.15% net margin, a stark contrast to the Q1 2026 net loss of $201.3 million and the Q4 2024 loss of $413.8 million. Gross margin in Q2 2026 was 8.93%, up from a negative 2.66% in Q1 2026 and a negative 5.93% in Q4 2024, while the trailing gross margin of 5.30% reflects the drag from those loss quarters. Operating margin of 3.69% and EBITDA of $621.5 million in Q2 2026 (a 15.21% EBITDA margin) demonstrate meaningful operating leverage when cracks are wide, but the razor-thin 5.3% gross margin underscores how little cushion exists if margins revert. For a refiner, single-digit gross margins are typical, but the volatility between negative and positive gross margins quarter-to-quarter highlights the binary nature of the earnings profile. The balance sheet is the most significant risk factor: debt-to-equity stands at 11.70, total debt-to-capitalization is 88.51%, and the current ratio of 0.818 indicates current liabilities exceed current assets, signaling tight near-term liquidity. Free cash flow tells a more encouraging story — TTM FCF is $684.9 million, and quarterly FCF has been positive in three of the last four quarters ($278.4 million in Q1 2026, $386.4 million in Q4 2025, $84.1 million in Q2 2026) — but capital expenditures are heavy at $173.8 million in Q2 2026 alone. ROE is negative at -7.96% on a trailing basis due to the loss quarters, and ROA is a modest 5.49%, suggesting the company is not yet generating returns above its cost of capital on a full-cycle basis. The cash position of $628.6 million provides some buffer, but with interest expense running at $100.1 million per quarter, the company is heavily dependent on sustained margin strength to service its obligations.
Quarterly Revenue
$4.1B
2026-06
Revenue YoY Growth
+47.8%
YoY Comparison
Gross Margin
8.9%
Latest Quarter
Free Cash Flow
$684900000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is DK Overvalued?
Because Delek's trailing net income is negative (EPS of -$0.013, trailing PE of -78.05), the PE ratio is not meaningful as a primary metric; instead, the forward PE of 8.99x — based on consensus estimated EPS of $7.70 — is the appropriate lens, and the enormous gap between the negative trailing and positive forward multiple implies the market expects a full earnings recovery that has already begun materializing in Q2 2026. The price-to-sales ratio of 0.168 is exceptionally low, reflecting the high-revenue, low-margin nature of refining, while the EV/EBITDA of 5.79x and EV/Sales of 0.63 provide more balanced cross-checks that suggest the stock is not expensive on an enterprise basis. The PEG ratio of 0.816 — below 1.0 — implies the forward earnings multiple is cheap relative to expected growth, a classic value signal for a cyclical at the early-to-mid stage of an upcycle. Against the broader energy sector, Delek's forward PE of 8.99x is at a discount to the typical integrated major (often 12-14x) but roughly in line with independent refiners, which commonly trade in the 8-12x forward range depending on the cycle. The price-to-book ratio of 6.28 is elevated for a refiner — most trade between 1.5x and 3x — reflecting the market's willingness to pay up for the current earnings surge, though this also means book value provides little downside support. The EV/EBITDA of 5.79x is the most compelling metric, sitting below the 6-8x range typical for refiners and suggesting the enterprise is undervalued relative to its cash-generating capacity. Historically, Delek's price-to-sales ratio has ranged from roughly 0.31 (Q2 2022) to 1.02 (Q1 2026), and the current 0.168 is at the very bottom of that band — though this partly reflects the revenue surge rather than a cheap stock. The PE ratio history is volatile and largely unusable given the string of loss quarters, but the price-to-book history shows the stock traded between 1.5x and 2.3x in 2022-2023 before the current 6.28x, indicating the market is pricing in a structurally higher earnings plateau that may or may not be justified by the cyclical margin environment.
PE
-78.1x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 1x~28x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
5.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are significant, primarily due to the company's highly leveraged balance sheet. With a debt-to-equity ratio of 11.70 and total debt-to-capitalization at 88.51%, Delek carries a heavy debt burden that consumes a substantial portion of earnings; interest expense was $100.1 million in Q2 2026 alone. The current ratio of 0.818 indicates that current liabilities exceed current assets, posing a near-term liquidity risk if cash flows deteriorate. Additionally, the company's profitability is highly volatile, with gross margins swinging from negative 2.66% in Q1 2026 to positive 8.93% in Q2 2026, and a trailing net margin of -0.21%, highlighting the binary nature of earnings in the refining sector.
Market and competitive risks are elevated given the stock's recent massive run-up and premium valuation on certain metrics. The price-to-book ratio of 6.28 is well above the typical 1.5x-3x range for refiners, suggesting that any disappointment in earnings could lead to multiple compression. The beta of 0.569 is relatively low, implying lower historical volatility compared to the S&P 500, but the recent 18% five-day drawdown shows that realized volatility can spike sharply around margin-driven news. Competitive risks include the potential for new refining capacity or a resolution of geopolitical tensions that could quickly erode the current margin windfall. Recent news highlights the dilutive equity offering at Delek Logistics and the reliance on a competitor's refinery outage, which are temporary factors that could reverse.
In a worst-case scenario, a normalization of refining margins due to easing geopolitical tensions or increased supply could cause a sharp earnings decline, exacerbating the leverage concerns. The stock could retrace to its 52-week low of $25.85, representing a 65% decline from the current price of $74.19. Even a more moderate bear case, such as the analyst low target of $52, implies a 30% downside. Given the high debt and low current ratio, a margin downturn could also trigger liquidity issues, potentially leading to a more severe sell-off. Investors could lose 30-65% of their investment in such an adverse scenario.
FAQ
The most severe risk is financial: the debt-to-equity ratio of 11.70 and current ratio of 0.818 indicate high leverage and tight liquidity, which could lead to solvency concerns if cash flows decline. Second, the company is highly exposed to refining margin volatility; a normalization of crack spreads could rapidly reverse profitability, as seen in Q1 2026 when Delek posted a $201.3 million net loss. Third, competitive and geopolitical risks: the current margin windfall is partly due to a competitor's refinery outage and the Iran conflict, both of which could reverse. Fourth, valuation risk: the price-to-book of 6.28 leaves little downside support, and the wide analyst target range of $52-$90 reflects high uncertainty. These risks are ranked in order of severity, with financial leverage being the most critical.
The 12-month forecast for DK is balanced, with a base case probability of 50% targeting a range of $70-$80, a bull case of 25% targeting $85-$90, and a bear case of 25% targeting $52-$60. The base case assumes refining margins moderate but remain above mid-cycle levels, allowing the stock to trade around the analyst average target of $74.58. The bull case hinges on sustained geopolitical disruptions and successful deleveraging, while the bear case assumes margin normalization and potential liquidity issues. The most likely scenario is the base case, as it aligns with current analyst estimates and the stock's recent trading range. Key assumptions include stable crack spreads and no major operational disruptions.
DK's valuation is mixed, with the stock appearing undervalued on forward earnings but overvalued on book value. The forward PE of 8.99x is below the 12-14x typical for integrated majors, and the PEG ratio of 0.816 is under 1.0, suggesting the market is not fully pricing in expected growth. However, the price-to-book ratio of 6.28 is well above the 1.5x-3x range for refiners, indicating a premium that may not be justified. The EV/EBITDA of 5.79x is below the 6-8x sector range, supporting the undervaluation case. Overall, the market appears to be pricing in a sustained earnings recovery, but the cyclical nature of refining means these multiples could quickly become expensive if margins fall.
DK is a speculative buy at best, with significant caveats. The stock has rallied 129.76% over the past year and 149.13% YTD, and now trades at $74.19, essentially at the analyst average target of $74.58, implying zero upside based on consensus. The forward PE of 8.99x and PEG of 0.816 suggest undervaluation, but these metrics are based on peak cyclical earnings that may not persist. The biggest downside risk is a margin normalization that could send the stock back to the $52 analyst low target, a 30% decline. For risk-tolerant investors seeking exposure to refining margins, DK could be a tactical buy on pullbacks, but it is not suitable for conservative portfolios given the 11.70 debt-to-equity ratio and 0.818 current ratio.
DK is more suitable for short-to-medium-term trading rather than long-term investment due to its cyclical earnings, high leverage, and lack of dividend sustainability (negative payout ratio). The stock's beta of 0.569 suggests lower historical volatility, but realized volatility has been high, with an 18% drawdown in five days. The dividend yield of 3.44% is attractive, but the negative payout ratio raises concerns about its continuation. Earnings visibility is low, with a 65% spread in analyst EPS estimates. A suggested holding period is 6 to 12 months, allowing time for margin trends to play out, but investors should monitor leverage and liquidity closely. Long-term investors may prefer more diversified energy names with stronger balance sheets.